Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29263277 | 0.98 | NAAA (0.35) | NAAACYP4F2CYP4A11ALDH1A1EPHX1 | |
| SCHEMBL14296145 | 0.94 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL10044939 | 0.85 | EGFR (0.33) | — | |
| SCHEMBL17461875 | 0.84 | HCAR2 (0.31) | NAAACYP4F2CYP4A11 | |
| SCHEMBL4452698 | 0.83 | DGKA (0.47) | CYP4F2CYP4A11ALDH1A1CYP3A4TSHR | |
| SCHEMBL4620336 | 0.82 | NAAA (0.33) | NAAACYP4F2CYP4A11ALDH1A1EPHX1 | |
| SCHEMBL27982814 | 0.82 | NAAA (0.44) | NAAAALDH1A1EPHX1CYP3A4TSHR | |
| SCHEMBL8421539 | 0.82 | NAAA (0.44) | NAAAALDH1A1EPHX1CYP3A4TSHR | |
| SCHEMBL23768094 | 0.80 | CYP4F2 (0.34) | CYP4F2CYP4A11 | |
| SCHEMBL9480850 | 0.79 | ALDH1A1 (0.40) | NAAAALDH1A1EPHX1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105916928-B | The manufacturing method of adhesive resin and the manufacturing method of resin combination and adhesive resin and resin combination | 昭荣化学工业株式会社 | 2019-01-08 | — | — | CN | disclosed |
| CN-105916928-A | Method for producing binder resin, method for producing resin composition, binder resin, and resin composition | 昭荣化学工业株式会社 | 2016-08-31 | — | — | CN | disclosed |
| US-20160022829-A1 | TUBULYSIN COMPOUNDS AND CONJUGATES THEREOF | MERSANA THERAPEUTICS, INC. | 2016-01-28 | — | — | US | disclosed |
| US-4997808-A | Superconductive ceramic oxide combination | EASTMAN KODAK COMPANY (US) | 1991-03-05 | — | — | US | disclosed |
| EP-0376862-A2 | A superconductive ceramic oxide combination | EASTMAN KODAK COMPANY (US) | 1990-07-04 | — | — | EP | disclosed |
| EP-0305965-A1 | Process for preparing esters of unsaturated alcohols | UNION CARBIDE CORPORATION (US) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160022829-A1 | TUBULYSIN COMPOUNDS AND CONJUGATES THEREOF | LGMN, TLL1, TEK | NAAA 3475/4885CYP4F2 3491/4885CYP4A11 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.